drugset / Trial / NCT01995032

L-citrulline and Metformin in Duchenne's Muscular Dystrophy

NCT01995032

Phase 3 Completed 47 enrolled University Hospital, Basel, Switzerland
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to show that the intake of L-citrulline and metformin improves muscle function and delay of progression in patients with Duchenne's muscular dystrophy.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject L-citrulline Other / unclassified 2.5 g Oral
Subject Metformin Small molecule 250 mg Oral